ATTR AMYLOIDOSIS
Clinical trials for ATTR AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new ATTR AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for ATTR AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New PET scan could spot rare heart disease faster
Diagnosis Recruiting nowThis study tests whether a special PET scan using a radioactive tracer called [18F]Florbetaben can accurately diagnose cardiac AL amyloidosis, a rare condition where abnormal proteins build up in the heart. About 200 adults with suspected cardiac amyloidosis will receive one inje…
Matched conditions: ATTR AMYLOIDOSIS
Phase: PHASE3 • Sponsor: Life Molecular Imaging GmbH • Aim: Diagnosis
Last updated May 13, 2026 16:03 UTC
-
Massive global study aims to unlock secrets of rare heart and nerve disease
Knowledge-focused Recruiting nowThis study is following 1,500 people with ATTR amyloidosis, a rare disease that damages the heart and nerves, to better understand how the condition progresses and how it is managed in everyday medical practice. Researchers will also track the safety and effectiveness of two appr…
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 03:08 UTC
-
Massive Real-World study launches to track ATTR amyloidosis journey
Knowledge-focused Recruiting nowThis study will follow over 52,000 people with ATTR amyloidosis, a rare disease where abnormal protein builds up in organs. Researchers will look at medical records to see how the disease is diagnosed, what treatments people receive, and how their health changes over time. The go…
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 03:00 UTC
-
New italian registry aims to unlock secrets of rare heart disease
Knowledge-focused Recruiting nowThis study is creating a large online registry of 1,000 people with ATTR amyloidosis, a rare disease where abnormal proteins build up in organs. Researchers will collect information from diagnosis through follow-up to learn how the disease progresses in real life. The goal is to …
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC